News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Analyst action
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article reports that Cingulate Inc. filed a Form 8K on August 13. The filing is brief and does not provide specific details about the content of the Form 8K. It notes that the information
Cingulate Inc. reported its Q2 2026 financial results, showing no product revenue and a net loss of $5.87 million, an increase from $4.98 million in the prior-year quarter. Key business developments include receiving an FDA complete response letter for CTx-1301 requesting additional CMC data, …
Cingulate Inc. reported a net loss of $5.9 million for the second quarter of 2026, with cash and cash equivalents totaling $28.4 million. The company is preparing for a resubmission of its CTx-1301 ADHD treatment NDA following an FDA Complete Response Letter. Cingulate anticipates …
Cingulate reported its second-quarter 2026 financial results, showing $28.4 million in cash and cash equivalents and a net loss of $5.9 million. The company expects its cash runway to extend into mid-2027 as it progresses with NDA resubmission work for CTx-1301 and builds commercial …
Cingulate Inc. (NASDAQ:CING) reported a net loss of $5.9 million for Q2 2026 and announced plans to resubmit its New Drug Application for CTx-1301, an ADHD treatment, after receiving a Complete Response Letter from the FDA requesting additional chemistry, manufacturing, and controls information. The …
Cingulate Inc. reported its second-quarter 2026 financial results, highlighting $28.4 million in cash and cash equivalents, expected to fund operations into mid-2027. The company is advancing its CTx-1301 ADHD drug toward NDA resubmission following an FDA Complete Response Letter and secured a new U.S. …
Cingulate Inc. (NASDAQ: CING) announced the publication of peer-reviewed data in CNS Drugs detailing the pharmacokinetic profile of its lead ADHD product candidate, CTx-1301. The study demonstrated that CTx-1301 provides rapid initial dexmethylphenidate exposure comparable to existing treatments, but crucially maintains statistically higher plasma …
Cingulate (CING) is projected to report its Q2 2026 earnings before market open on Tuesday, August 18th, with analysts forecasting a loss of $0.63 per share and revenue of $167,000. The company previously missed Q1 2026 consensus estimates with a loss of $0.95 per …
Cingulate Inc. announced the publication of "Comparative Bioavailability of Trimodal CTx-1301 Versus Bimodal Dexmethylphenidate" in CNS Drugs, showcasing the differentiated pharmacokinetic profile of its lead ADHD product candidate, CTx-1301. The study supports Cingulate’s Precision Timed Release™ (PTR™) platform, demonstrating rapid onset and extended medication …
This article provides an earnings forecast for Singularity Future Technology Ltd (SGLY), focusing on future EPS and revenue growth estimates. It includes current stock information, a market overview, and lists peer comparisons for the company within the Freight & Logistics Services sector. The content …
This article provides a brief update on Singularity Future Technology Ltd (SGLY) stock news, indicating that more news is coming soon. As of August 7th, 16:00 ET, SGLY stock closed at $6.870, up $0.190 (+2.84%). The company has a market cap loss of $6.16 …
Singularity Future Technology (SGLY) saw its stock short interest rise significantly to 57.11% of the float as of July 15th, an increase of over 1,000% from June 30th. This surge in short interest translates to 512,214 shares, and it is estimated that short sellers …
This article provides the "Price to book forward" financial metric for Cingulate Inc. (NASDAQ: CINGW). It is presented as a snapshot from TradingView, indicating the period, value, and change percentage for this financial data point.
This article provides a risk assessment for Singularity Future Technology Ltd (SGLY), highlighting its current risk score of 1.49 and its ranking within the Freight & Logistics Services industry. It details the company's beta value, indicating its volatility relative to the S&P 500 index, …
This article provides a financial overview of Cingulate Inc. (NASDAQ: CING), focusing on its revenue breakdown. It points to sections like "Fundamentals and stats," "Overview," "Statements," "Statistics," "Dividends," "Earnings," and "Segments" for detailed financial information. The content itself is very brief and seems to …
This article provides a technical analysis of Singularity Future Technology Ltd (SGLY), detailing its support and resistance levels, indicator values, and moving averages. As of the update, SGLY has a price momentum score of 9.73, trading between a resistance of 6.49 and support of …
Cingulate Inc. announced the publication of its Phase 3 clinical trial results for CTx-1301, a treatment for ADHD, in the Journal of Child and Adolescent Psychopharmacology. The study demonstrated clinically meaningful improvements in ADHD symptoms with a favorable safety profile, reinforcing the potential of …
Cingulate announced the publication of Phase 3 trial results for its lead ADHD candidate, CTx-1301 (dexmethylphenidate HCl), in the Journal of Child and Adolescent Psychopharmacology. The study showed that all three tested doses of CTx-1301 significantly improved ADHD Rating Scale-5 scores compared to placebo, …
This article provides a technical analysis of Cingulate Inc (CING), detailing its performance based on various indicators and moving averages. It covers key metrics like MACD, RSI, and different moving average values (MA5, MA10, etc.), summarizing the current signals as "Neutral" based on a …
This article from TradingKey provides an overview of Singularity Future Technology Ltd (SGLY)'s institutional confidence, detailing changes in shareholdings by various investment firms. Key institutions like Citi Investment Research (US) and UBS Financial Services, Inc. show significant increases in their SGLY holdings, while others …
Singularity Future Technology Ltd (SGLY) currently has a weak financial status with a score of 5.02, ranking 74 out of 75 in the Freight & Logistics Services industry. Despite this, its latest quarterly revenue saw an 11.19% year-over-year increase, and net profit surged by …
The article focuses on the net income before discontinued operations of Singularity Future Technology Ltd., identified by the stock symbol FWB:4GS0 on the Frankfurt Stock Exchange. It appears to be a financial data snippet from TradingView, indicating that there were no trades for the …
This article provides financial information for Singularity Future Technology Ltd. (FWB:4GS0) on TradingView. It highlights the "Cash per share" metric for the company, accessible through its financial overview on the platform. The content is primarily a listing of navigation and footer elements typical of …
This page provides financial data for Cingulate Inc. (NASDAQ: CINGW), specifically its enterprise value to EBITDA forward. It notes that the market is currently closed with no trades. The content briefly touches on various market data services and TradingView's offerings without providing detailed financial …
This article provides a valuation analysis of Singularity Future Technology Ltd (SGLY). The company currently has a valuation score of 8.98, ranking it 16th out of 75 in the Freight & Logistics Services industry. Key financial ratios like P/E, P/B, P/S, and P/CF are …
This article provides a detailed cash flow statement for Cingulate Inc (CING), including operating, investing, and financing cash flows presented quarterly and annually. It also includes key financial figures and answers frequently asked questions about different types of cash flow and their significance for …
This article provides the quarterly and annual income statements for Cingulate Inc. (CING), detailing key financial metrics such as operating expenses, R&D expenses, operating profit, and net income over several fiscal years and quarters. It also includes an FAQ section explaining how to read …
This article provides financial information for Singularity Future Technology Ltd. (FWB:4GS0), specifically focusing on its non-operating income. It appears to be a financial data snapshot from a platform like TradingView, displaying key metrics like period, value, and percentage change. The content highlights the company's …
This article provides a detailed income statement for Singularity Future Technology Ltd (SGLY) on TradingKey. It breaks down quarterly and annual financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings per share. Additionally, it offers frequently …
Search by ticker symbol or company name and select a result to open its chart.